Wu Wei - Net Worth and Insider Trading
Wu Wei Net Worth
The estimated net worth of Wu Wei is at least $17 Million dollars as of 2025-07-19. Wu Wei is the senior management of Chengdu Olymvax Biopharmaceuticals Inc and owns about 778,400 shares of Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) stock worth over $17 Million. Details can be seen in Wu Wei's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wu Wei has not made any transactions after 2024-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Wu Wei
Wu Wei Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wu Wei owns 1 companies in total, including Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) .
Click here to see the complete history of Wu Wei’s form 4 insider trades.
Insider Ownership Summary of Wu Wei
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:688319 | Chengdu Olymvax Biopharmaceuticals Inc | 2024-07-15 | senior management |
Wu Wei Latest Holdings Summary
Wu Wei currently owns a total of 1 stock. Wu Wei owns 778,400 shares of Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) as of July 15, 2024, with a value of $17 Million.
Latest Holdings of Wu Wei
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:688319 | Chengdu Olymvax Biopharmaceuticals Inc | 2024-07-15 | 778,400 | 21.61 | 16,821,224 |
Holding Weightings of Wu Wei
Wu Wei Form 4 Trading Tracker
According to the SEC Form 4 filings, Wu Wei has made a total of 3 transactions in Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Chengdu Olymvax Biopharmaceuticals Inc is the sale of 27,600 shares on July 15, 2024, which brought Wu Wei around $292,836.
Insider Trading History of Wu Wei
- 1
Wu Wei Trading Performance
GuruFocus tracks the stock performance after each of Wu Wei's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Wei is -25.09%. GuruFocus also compares Wu Wei's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Wei within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wu Wei's insider trading performs compared to the benchmark.
Performance of Wu Wei
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.37 |  | | | | |
| Relative Return to S&P 500(%) | -10.56 | | | | | |
Wu Wei Ownership Network
Ownership Network List of Wu Wei
Ownership Network Relation of Wu Wei
Wu Wei Owned Company Details
What does Chengdu Olymvax Biopharmaceuticals Inc do?
Who are the key executives at Chengdu Olymvax Biopharmaceuticals Inc?
Wu Wei is the senior management of Chengdu Olymvax Biopharmaceuticals Inc. Other key executives at Chengdu Olymvax Biopharmaceuticals Inc include Core technical personnel Wu Qiang , Core technical personnel Chen Dao Yuan , and Core technical personnel Li Hong Guang .
Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) Insider Trades Summary
Over the past 18 months, Wu Wei made 1 insider transaction in Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) with a net sale of 0. Other recent insider transactions involving Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) include a net sale of 214,054 shares made by Chen Dao Yuan , a net sale of 64,000 shares made by Li Hong Guang , and a net sale of 10,000 shares made by Wu Qiang .
In summary, during the past 3 months, insiders sold 70,000 shares of Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) in total and bought 0 shares, with a net sale of 70,000 shares. During the past 18 months, 288,054 shares of Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) were sold and 0 shares were bought by its insiders, resulting in a net sale of 288,054 shares.
Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chengdu Olymvax Biopharmaceuticals Inc Insider Transactions
Wu Wei Mailing Address
Above is the net worth, insider trading, and ownership report for Wu Wei. Currently GuruFocus does not have mailing address information for Wu Wei.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
